Cardiac allograft vasculopathy in pediatric heart transplant recipients

Transplant International

Volumn 19, Issue 3, 2006, Pages 184-189

  Hathout, Eba ^a   Beeson, W Lawrence ^a   Kuhn, Micheal ^a   Johnston, Joyce ^a   Fitts, James ^a   Razzouk, Anees ^a   Bailey, Leonard ^a   Chinnock, Richard E ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Allograft vasculopathy; Heart transplant; Pediatric

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; GLUCOCORTICOID; HLA DR ANTIGEN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ADOLESCENT; ANGIOGRAPHY; ARTICLE; AUTOPSY; CARDIAC ALLOGRAFT VASCULOPATHY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PACEMAKER; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADOLESCENT; ANGIOGRAPHY; AUTOPSY; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CYCLOSPORINE; FEMALE; GLUCOSE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; LIPIDS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 33645341453     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00255.x     Document Type: Article

References (29)

1. Soukiasian HJ Czer LS Wang HM et al. Inhibition of graft coronary arteriosclerosis after heart transplantation Am Surg 2004 70 833
2. Chinnock RE Cutler D Baum M Clinical outcome 10 years after infant heart transplantation Prog Pediatr Cardiol 2000 11 165
3. Webber SA Naftel DC Parker J et al. Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes J Heart Lung Transplant 2003 22 869
4. Kirklin JK Benza RL Rayburn BK McGiffin DC Strategies for minimizing hyperlipidemia after cardiac transplantation Am J Cardiovasc Drugs 2002 2 377
5. Kato T Chan MC Gao SZ et al. Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease J Am Coll Cardiol 2004 43 1034
6. Guo H Lee JD Xing Y et al. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation Acta Cardiol 2004 59 503
7. Kutschka I Pethig K Harringer W Haverich A Struber M Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy J Heart Lung Transplant 2004 23 1260
8. Dobbels F De Geest S van Cleemput J Droogne W Vanhaecke J Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up J Heart Lung Transplant 2004 23 1245
9. Itescu S Tung TC Burke EM et al. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients Lancet 1998 352 263
10. Labarre CA Nelson DR Pitts DE Kirlin PC Halbrook H Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patients Am J Transplant 2001 1 251
11. Luo W Liu A Chen Y et al. Inhibition of accelerated graft arteriosclerosis by gene transfer of soluble fibroblast growth factor receptor-1 in rat aortic transplants Arterioscler Thromb Vasc Biol 2004 24 1081
12. Matsuno Y Iwata H Yoshikawa S et al. Suppression of graft coronary arteriosclerosis by gene gun-mediated CTLA4-Ig gene transfer Transplant Proc 2002 34 2619
13. Reinsmoen NL Nelson K Zeevi A Anti-HLA antibody analysis and crossmatching in heart and lung transplantation Transpl Immunol 2004 13 63
14. Shirali GS Ni J Chinnock RE et al. Association of viral genome with graft loss in children after cardiac transplantation N Engl J Med 2001 344 1498
15. Ringewald JM Gidding SS Crawford SE Backer CL Mavroudis C Pahl E Nonadherence is associated with late rejection in pediatric heart transplant recipients J Pediatr 2001 139 75
16. Vrtovec B Thomas CD Radovancevic R Frazier OH Radovancevic B Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients J Heart Lung Transplant 2004 23 461
17. Penson MG Winter WE Fricker FJ et al. Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients J Heart Lung Transplant 1999 18 707
18. Moien-Afshari F McManus BM Laher I Immunosuppression and transplant vascular disease: benefits and adverse effects Pharmacol Ther 2003 100 141
19. Webber SA The current state of, and future prospects for, cardiac transplantation in children Cardiol Young 2003 13 64
20. Shiba N Chan MC Kwok BW Valantine HA Robbins RC Hunt SA Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience J Heart Lung Transplant 2004 23 155
21. Valantine H Cardiac allograft vasculopathy after heart transplantation: risk factors and management J Heart Lung Transplant 2004 23 S187
22. Mulla NF Johnston JK Vander Dussen L et al. Late rejection is a predictor of transplant coronary artery disease in children J Am Coll Cardiol 2001 37 243
23. Hathout EH Chinnock RE Johnston JK et al. Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients Am J Transplant 2003 3 994
24. Trapp A Weis M The impact of immunosuppression on endothelial function J Cardiovasc Pharmacol 2005 45 81
25. Radu RG Fujimoto S Mukai E et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity Am J Physiol Endocrinol Metab 2005 288 E365
26. Bailey LL Zuppan CW Chinnock RE Johnston JK Razzouk AJ Gundry SR Graft vasculopathy among recipients of heart transplantation during the first 12 years of life. The Pediatric Heart Transplant Group Transplant Proc 1995 27 1921
27. Petrakopoulou P Kubrich M Pehlivanli S et al. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function Circulation 2004 110 II207
28. Wijngaard PL Tuijnman WB Gmelig Meyling FH et al. Endomyocardial biopsies after heart transplantation. The presence of markers indicative of activation Transplantation 1993 55 103
29. De Mattos AM Head MA Everett J et al. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used Transplantation 1994 57 626